Patient Guide: A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 68 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07222917
Status: NOT_YET_RECRUITING
Condition: Chronic Kidney Disease and Hypertension
Phase: PHASE2

Where You Can Participate

This study is available at 68 locations across the country.

Top locations include:
  • • Surprise, Arizona
  • • Hollywood, Florida
  • • Port Charlotte, Florida
  • • And 65 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure. - Join Clinical Trial NCTNCT07222917

How to Join This Clinical Trial - NCTNCT07222917

Learn how to participate in this PHASE2 trial studying an investigational therapy for Chronic Kidney Disease and Hypertension. Current status: NOT_YET_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Kidney Disease and Hypertension. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Kidney Disease and Hypertension
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
NOT_YET_RECRUITING
Study Identifier
NCTNCT07222917 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 68 locations. Find a study site near you:

Clinical Research Site

Surprise, Arizona 85374 - United States

Status: Contact for availability

Clinical Research Site

Hollywood, Florida 33021 - United States

Status: Contact for availability

Clinical Research Site

Port Charlotte, Florida 33952 - United States

Status: Contact for availability

Clinical Research Site

Port Orange, Florida 32127 - United States

Status: Contact for availability

Clinical Research Site

Atlanta, Georgia 30344 - United States

Status: Contact for availability

Clinical Research Site

Champaign, Illinois 61822 - United States

Status: Contact for availability

Clinical Research Site

Wichita, Kansas 67214 - United States

Status: Contact for availability

Clinical Research Site

Eatontown, New Jersey 07724 - United States

Status: Contact for availability

Clinical Research Site

Greenville, North Carolina 27834 - United States

Status: Contact for availability

Clinical Research Site

Jacksonville, North Carolina 28546 - United States

Status: Contact for availability

And 58 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Chronic Kidney Disease and Hypertension:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships